EP Patent

EP2842549A1 — Orally disintegrating tablet and method for producing same

Assigned to Daiichi Sankyo Co Ltd · Expires 2015-03-04 · 11y expired

What this patent protects

Provided are an orally disintegrating tablet that quickly disintegrates when it is placed in the mouth or put into water, provides favorable taste, has a sufficient hardness in general production, transportation and use and is excellent in terms of storage stability, and a proces…

USPTO Abstract

Provided are an orally disintegrating tablet that quickly disintegrates when it is placed in the mouth or put into water, provides favorable taste, has a sufficient hardness in general production, transportation and use and is excellent in terms of storage stability, and a process for the production of the same which is excellent in terms of industrial production. An orally disintegrating tablet containing a drug, a crystalline cellulose having a bulk density of 0.23 g/cm 3 or less (preferably from 0.10 g/cm 3 to 0.23 g/cm 3 ), a sugar alcohol and a pregelatinized starch.

Drugs covered by this patent

Patent Metadata

Patent number
EP2842549A1
Jurisdiction
EP
Classification
—
Expires
2015-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Daiichi Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.